Rugo Highlights Latest Advances in TNBC Treatment Clinical trials are now investigating a number of different avenues for patients with.
Clinical Phase Ib Trial of L-NMMA Plus Docetaxel in the Treatment of Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients.
Primary Purpose: Treatment. Official Title: Triple Negative Trial: A Randomised Phase III Trial of Carboplatin Compared to Docetaxel for Patients With Metastatic .
Neoadjuvant breast cancer clinical trials pre, including patients with triple- negative breast cancer and showing modest pathological.
Triple-negative breast cancer (TNBC) is known to have a poor prognosis and In addition, we summarize the ongoing phase III clinical trials.